Subscribe

Ochsner CEO Calls for Adding Value in Healthcare

VBCC - March 2013, Volume 4, No 3 - Health Policy
Caroline Helwick

New Orleans, LA—“We must start to think differently if we want to change the healthcare system,” said Ochsner Health System President and CEO Warner L. Thomas, CPA, MBA, FACHE, in a keynote address at the 2013 Health Information and Management Systems Society (HIMSS) annual conference. “We are seeing the most significant changes in healthcare in 30 years.”

Ochsner is a 71-year-old institution, with 8 hospitals and almost $2 billion in revenue. It is now 70% of the way toward an information technology (IT) conversion from a homegrown electronic health record to Epic systems software—in just 15 months—and 100% of its 900 physicians have met meaningful-use criteria.

The country’s fiscal situation, the unaffordability of healthcare for consumers, and the reductions in payments to providers and hospitals create a crisis that requires health systems to be more proactive than ever, he said. “What are we going to do about it?” Mr Thomas asked. “We’ve got to shift from a volume mentality into value. We’ve got to be thinking differently.”

Problem solving and coping with change is all about “perspective,” he suggested. “We control our perspective. If we’re not optimistic and energized, we will not be successful. We’re going to set the stage now for the next 10, 15, 20 years.”

Challenges and Solutions
Ochsner’s mission, Mr Thomas noted, is to provide an experience for patients that makes them want to come back, to improve clinical outcomes, and to become more affordable for patients.

Success starts with the health IT leaders, he said, who should ensure that systems provide better, safer patient experiences; optimize the use of systems to their full potential; be proactive and use systems to solve and improve on what patients want and need; and use IT to improve the productivity and efficiency of employees.

This requires that health IT be developed with the broad context in mind. For example, a successful “go live” is a very good start, rather than the end game. “I think we need to redefine what a good installation is,” Mr Thomas explained. “Does it provide higher quality healthcare cost-effectively? Are the physicians happier? We don’t expect IT to drive all the change, but we expect it to be a driver….And I would add this advice to IT leaders: add value.”

Related Items
FDA Taking Steps to Promote Generic Drug Competition and Improve Patient Access to Therapies
Eileen Koutnik-Fotopoulos
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Health Policy
Medical Groups Applaud Congressional Leaders for Agreement to Repeal Medicare Therapy Caps
Anne Rowe
VBCR - December 2017, Vol 6, No 5 published on December 19, 2017 in Health Policy
ACR Responds to 2019 Benefit and Payment Parameters Proposed Rule
Anne Rowe
VBCR - December 2017, Vol 6, No 5 published on December 19, 2017 in Health Policy
Support Continues to Grow for Step Therapy Reform
Rebecca Bailey
VBCR - December 2017, Vol 6, No 5 published on December 19, 2017 in Health Policy
Use of Conventional Synthetic versus Biologic Disease-Modifying Antirheumatic Drugs May Reduce Costs in Treatment of RA
Leslie Wyatt
VBCR - December 2017, Vol 6, No 5 published on December 19, 2017 in Health Policy
Can Some Patients with Multiple Sclerosis Stop Treatment?
Caroline Helwick
Web Exclusives published on August 30, 2017 in Multiple Sclerosis
Oral Ozanimod: A Safer Sphingosine-1-Phosphate Receptor Modulator?
Caroline Helwick
Web Exclusives published on June 26, 2017 in Multiple Sclerosis
Vitamin D Supplementation Shows Benefits in Multiple Sclerosis, but Questions Remain
Caroline Helwick
Web Exclusives published on March 31, 2017 in Multiple Sclerosis
Ocrelizumab Receives Breakthrough Therapy for Progressive Multiple Sclerosis
Caroline Helwick
VBCN - April 2016 Volume 3, No 1 published on May 3, 2016 in Multiple Sclerosis
Ozanimod Achieves Very Low Relapse Rate in MS
Caroline Helwick
VBCN - April 2016 Volume 3, No 1 published on May 3, 2016 in Multiple Sclerosis
Last modified: May 28, 2014
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology